Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04327518
Other study ID # NXGT-202-QROS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 11, 2020
Est. completion date June 1, 2021

Study information

Verified date May 2022
Source Johnson & Johnson Surgical Vision, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, multicenter, single-arm, open-label clinical study of the commercially available TECNIS Toric II IOL. The study will be conducted in up to 192 subjects needing unilateral or bilateral cataract surgery in up to 8 sites in United States (US). The subjects will be followed for up to 3-months postoperatively.


Recruitment information / eligibility

Status Completed
Enrollment 125
Est. completion date June 1, 2021
Est. primary completion date April 6, 2021
Accepts healthy volunteers No
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: 1. Minimum 22 years of age; 2. Unilateral or Bilateral cataracts for which cataract extraction and posterior chamber IOL implantation have been planned; 3. Pre-existing corneal astigmatism of one diopter or greater; 4. Predicted residual refractive cylinder based on toric IOL calculator, considering surgically induced astigmatism (SIA) and posterior corneal astigmatism (PCA) must be =0.50 D; 5. Potential for postoperative BCDVA of 20/30 Snellen or better; 6. Clear intraocular media other than cataract in each eye; 7. Availability, willingness and sufficient cognitive awareness to comply with examination procedures and study visits; 8. Signed informed consent form (ICF) and health insurance portability and accountability act (HIPAA) authorization; 9. Ability to understand and respond to a questionnaire in English. Exclusion Criteria: 1. Irregular corneal astigmatism; 2. Any corneal pathology/abnormality other than regular corneal astigmatism or corneal instability due to contact lens wear; 3. Previous corneal or intraocular surgery; 4. Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.); 5. Any pupil abnormalities (non-reactive, fixed, or abnormally shaped pupils); 6. Dilated pupil size of < 6.0 mm; 7. Recurrent severe anterior or posterior segment inflammation or uveitis; 8. Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, or posterior capsule defects; 9. Known ocular or systemic disease that, in the opinion of the investigator, may affect visual acuity or require surgical intervention during the course of the study, [macular degeneration, cystoid macular edema, proliferative diabetic retinopathy (severe), uncontrolled glaucoma, irregular corneal astigmatism, choroidal hemorrhage, concomitant severe eye disease, extremely shallow anterior chamber, microphthalmos, non-age related cataract, severe corneal dystrophy, severe optic nerve atrophy, etc.]; 10. Use of systemic or ocular medications (e.g., Flomax) that may affect vision including prior, current, or anticipated use during the course of the study that may, in the opinion of the investigator, confound the outcome or increase the risk to the subject (e.g., poor dilation or a lack of adequate iris structure to perform standard cataract surgery); 11. Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes; 12. Concurrent participation or participation within 30 days prior to the preoperative visit in any other clinical study. 13. Planned monovision correction (eye designated for near correction)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TECNIS® Toric II
Toric Intraocular Lens

Locations

Country Name City State
United States Empire Eye and Laser Center, Inc. Bakersfield California
United States Cincinnati Eye Institute Cincinnati Ohio
United States JW Eye Associates, P.A. DBA Key-Whitman Eye Center Dallas Texas
United States Texas Eye & Laser Center, P.A. Hurst Texas
United States University of California Los Angeles California
United States Jones Eye Clinic Sioux City Iowa
United States Vance Thompson Vision, ND W. Fargo North Dakota

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Surgical Vision, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Eyes With = 5º Lens Axis Misalignment From the Intended IOL Axis of Orientation at the 1-week Postoperative Visit Absolute difference between intended IOL axis of orientation (immediately at the end of surgery) and follow-up visit(s) were measured by a photographic based method. 1 week postoperative
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A